GSK Pharma surges 7%, nears record high on healthy business outlook

Since November, the stock has appreciated by 36% after the company reported earnings improvement in Q2FY24 on strong demand for its vaccines and general medicine.

Shares of GlaxoSmithKline Pharmaceuticals (GSK Pharma) hit a multi-year high of Rs 1,928.70, as they rallied 7 per cent on the BSE in Thursday’s intra-day trade on healthy business outlook.

The stock of pharmaceutical company was trading higher for the fifth straight day, surging 14 per cent during the period. It was quoting close to its record high of Rs 1,936 touched on March 31, 2016.

Since November, the stock has appreciated by 36 per cent after the company reported earnings improvement in September quarter (Q2FY24) on strong demand for its vaccines and general medicine.

Consolidated profit